| |
 |
|
|
Inventor: Lubisch; Wilfried
Address: Mannheim, DE
No. of patents: 25
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 6436949 |
Heterocyclically substituted benzamides and their use |
August 20, 2002 |
| Heterocyclically substituted benzamides of the formula I ##STR1##are described, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, X, m and n have the meanings given in the description. The novel compounds are useful for controlling diseases. |
| 6414157 |
3-Substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their |
July 2, 2002 |
| 3-substituted tetrahydropyridopyrimidinone derivatives of the formula (I) wherein the radicals have the meanings given in the Description, to a method for producing said derivatives and, to their use for producing active ingredients for drugs. ##STR1## |
| 6407109 |
Pyrrolyl tetrahydroquinoxalin diones, their production and use in the treatment of diseases |
June 18, 2002 |
| Pyrrolylquinoxalinediones of the formula I ##STR1##and their tautomeric and isomeric forms, and their physiologically tolerated salts, where the variables have the following meanings:R.sup.1hydrogen, cyclohexylan aliphatic radical which has 1 to 4 carbon atoms and can carry the radical - |
| 6380220 |
Derivatives from piperidine-keto acid, their preparation and use |
April 30, 2002 |
| Piperidineketocarboxylic acid derivatives of the general formula I ##STR1##and their tautomeric and isomeric forms, and physiologically tolerable salts thereof, where the variables have the meanings given in the description, preparation of these compounds and their use as drugs. |
| 6346622 |
2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5H |
February 12, 2002 |
| ##STR1##where the substituents have the meanings indicated in the description, their preparation and use as serotonin antagonists. |
| 6277850 |
Pyrrolyl quinoxalindiones their production and use as AMPA receptor antagonists |
August 21, 2001 |
| Pyrrolylquinoxalinediones of the formula I ##STR1##and their tautomeric and isomeric forms, and their physiologically tolerated salts are described, where the variables have the following meaning:R.sup.1 hydrogen, C.sub.1 -C.sub.6 -alkyl, substituted by hydroxyl or carboxyl,R.sup.2 h |
| 6251917 |
Benzamidoaldehydes and their use as cysteine protease inhibitors |
June 26, 2001 |
| Compounds of the formula ##STR1##where R.sup.1, R.sup.2, R.sup.3, X and n are as defined in the description, are inhibitors of cysteine protease. |
| 6222034 |
3-substituted pyrido[4',3':4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their |
April 24, 2001 |
| A 3-substituted 3,4,5,6,7,8-hexahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidine compound of formula I ##STR1##whereinR.sup.1 is hydrogen, C.sub.1 -C.sub.4 -alkyl, acetyl or benzoyl, optionally substituted phenyl-C.sub.1 -C.sub.4 -alkyl, naphthyl-C.sub.1 -C.sub.3 -alkyl, phenyl-C.su |
| 6172072 |
Heterocyclically substituted benzamides and their use in fighting diseases |
January 9, 2001 |
| Heterocyclically substituted benzamides of the formula I ##STR1##are described, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, X, m and n have the meanings given in the description. The novel compounds are useful for controlling diseases. |
| 6121265 |
Heterocyclic substituted imidazoloquinoxalinones, their preparation and their use |
September 19, 2000 |
| Imidazoloquinoxalinones of the formula ##STR1## where R.sup.1 -R.sup.5, A and B have the meanings stated in the description, and their preparation are described. The novel substances are suitable for controlling diseases. |
| 6103720 |
Ketobenzamides as calpain inhibitors |
August 15, 2000 |
| The patent describes ketobenzamides of the formula ##STR1## where R1, R2, R3, R4, X and n have the meanings given in the description, and their preparation. The novel compounds are useful for controlling disorders. |
| 5852017 |
2,3(1H,4H)-quinoxalinediones |
December 22, 1998 |
| 2,3(1H,4H)-quinoxalinediones of the formula I ##STR1## where R.sup.1 is hydrogen, an aliphatic radical which has up to 12 carbons and can be substituted by one of the following: phenyl, cyclopentyl, cyclohexyl or --CO--R.sup.3, --CO--O--R.sup.3 or --CO--NH--R.sup.3, where R.sup.3 |
| 5849744 |
Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor anta |
December 15, 1998 |
| Pyrrolyltetrahydrobenzoquinoxalinediones of the formula I ##STR1## and their tautomeric and isomeric forms, and their physiologically tolerated salts, in which the variables have the meanings stated in the description, and the preparation thereof are described. The novel compound |
| 5849743 |
Quinoxalines and drugs prepared therefrom |
December 15, 1998 |
| Quinoxaline-2,3-(1H,4H)-diones of the formula I ##STR1## and their tautomeric and enantiomeric forms and their physiologically tolerated salts, the variables R, R.sup.1 and R.sup.2 have the meanings specified in claim 1, and are useful for therapeutic treatment of neurodegenerati |
| 5773439 |
Amido-quinoxalinediones, the preparation and use thereof |
June 30, 1998 |
| Novel amido-quinoxalinediones of the formula ##STR1## where R.sup.1 -R.sup.5, n and m have the meanings stated in the description, and the preparation thereof are described. The compounds are suitable for controlling diseases. |
| 5714489 |
2,3(1H,4H)quinoxalinedione |
February 3, 1998 |
| 2,3(1H,4H)-quinoxalinediones of the formula I ##STR1## where R.sup.1 is hydrogen, an aliphatic radical which has up to 12 carbons and can be substituted by one of the following: phenyl, cyclopentyl, cyclohexyl or --CO--R.sup.3, --CO--O--R.sup.3 or --CO--NH--R.sup.3, where R.sup.3 |
| 5296485 |
Substituted N-phenylpiperidines and drugs therefrom |
March 22, 1994 |
| Substituted N-phenylpiperidines I ##STR1## (R.sup.1 =H, NO.sub.2, CN, halogen, C.sub.1 -C.sub.4 -alkyl, CF.sub.3, OCF.sub.3, OH, CH.sub.2 OH, COOH, CHO, NH--CHO, NH.sub.2, CO--NH.sub.2, 5-tetrazinyl, R.sup.4 --O--, R.sup.4 --O--CH.sub.2 --, R.sup.4 O--CO--, R.sup.4 --CO--, R.sup. |
| 5270325 |
P-hydroxy phenone derivatives used in the treatment of cardiac arrhythmia |
December 14, 1993 |
| p-hydroxy phenone derivatives of the formula I ##STR1## where X is ##STR2## where R.sup.1 =F, Cl, Br or trifluoromethyl or a heteroaryl of the structure ##STR3## with R.sup.2 =C.sub.1 -C.sub.4 -alkyl,Y is a bridging member of the formula --CH.dbd.CH--, --CH.sub.2 CH.sub.2 |
| 5260330 |
Substituted anilides |
November 9, 1993 |
| Substituted anilides of the formula I ##STR1## (where R.sup.1 is C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -haloalkyl, C.sub.1 -C.sub.4 -alkoxy, halogen, cyano, nitro, C.sub.2 -C.sub.4 -alkenyl, C.sub.2 -C.sub.4 -alkynyl;X is methylene, ethylene, vinylene;R.sup.2 and R.sup.3 are each |
| 5260318 |
Phenylpiperidylamines and drugs containing them |
November 9, 1993 |
| Phenylpiperidylamines of the formula I ##STR1## R.sup.1 is H, NO.sub.2, R.sup.4 SO.sub.2 NH, ##STR2## N.dbd.C, CF.sub.3, CF.sub.3 O, F, Cl, Br, C.sub.1 -C.sub.4 -alkyl, R.sup.3 O, CO.sub.2 R.sup.3, CHO, CH.dbd.NOR.sup.3, CH.sub.3 OR.sup.3 andR.sup.2 is H, F, Cl, Br, C.sub.1 -C.s |
| 5175174 |
Phenylpiperidinylamines and drugs containing these |
December 29, 1992 |
| Phenylpiperidinylamines of the formula I ##STR1## where R.sup.1 is --NHSO.sub.2 R.sup.4 or ##STR2## R.sup.2 and R.sup.3 are each, independently of one another, H or C.sub.1 -C.sub.4 -alkyl or together are a (CH.sub.2).sub.n chain with n=4 or 5, andR.sup.4 is C.sub.1 -C.sub.4 |
| 5118682 |
p-Hydroxy phenone derivatives and the use thereof |
June 2, 1992 |
| p-Hydroxy phenone derivatives of the general formula I ##STR1## where R.sup.1, R.sup.2 and R.sup.3 are identical or different and are methyl, chlorine, bromine and hydrogen, but R.sup.1, R.sup.2 and R.sup.3 are not all H,R.sup.4 and R.sup.5 are identical or different and are H, C.sub |
| 5055475 |
P-hydroxy phenone derivatives and drugs containing these |
October 8, 1991 |
| P-hydroxy phenone derivatives of the formula 1 ##STR1## where X is ##STR2## where R.sup.1 =F, Cl, Br or trifluoromethyl or a heteroaryl of the structure ##STR3## with R.sup.2 =C.sub.1 -C.sub.4 - alkyl,Y is a bridging member of the formula --CH.dbd.CH--, --CH.sub.2 CH.sub. |
| 4980361 |
P-hydroxy phenone derivatives and drugs containing these |
December 25, 1990 |
| Abstract of the disclosure: p-hydroxy phenone derivatives of the formula I ##STR1## where X is ##STR2## where R.sup.1 =F, Cl, Br or trifluoromethyl or a heteroaryl of the structure ##STR3## with R.sup.2 =C.sub.1 -C.sub.4 -alkyl, Y is a bridging member of the formula - |
| 4959373 |
Bispidine derivatives as class III antiarrhythmic agents |
September 25, 1990 |
| Bispidine derivatives of the formula I ##STR1## where R, R.sup.1 and R.sup.3 are identical or different and are each H, C.sub.1 -C.sub.4 -alkyl, halogen or C.sub.1 -C.sub.4 -alkoxy, when Y is ##STR2## R.sup.2 is C.sub.1 -C.sub.4 -alkyl, halogen, --CN, C.sub.1 -C.sub.4 -alkoxy |
|
|
|
